连续血液净化腹腔感染患者血清HNL与IL-6和PCT水平及其对预后的预测价值

Effect of continuous blood purification on serum HNL, IL-6, PCT and its prognostic value in patients with abdominal infection

  • 摘要: 目的 探讨连续性血液净化(CBP)腹腔感染(IAI)患者血清中性粒细胞载脂蛋白(HNL)、白细胞介素-6(IL-6)、降钙素原(PCT)水平及其对预后的预测价值。方法 选取2020年1月-2022年6月ICU收治的需行CBP治疗的IAI患者87例为研究对象,根据急性生理学及慢性健康状况Ⅱ(APACHE Ⅱ)评分分为轻中度组(APACHEⅡ≤10评分,50例)和重度组(APACHEⅡ评分>10,37例)。收集汇总纳入研究对象的临床资料,于患者入院时、治疗后3 d检测血清HNL、IL-6、PCT水平,随访28 d预后情况,采用受试者工作特征(ROC)曲线评估血清HNL、IL-6、PCT对预后的预测价值。结果 患者治疗后3 d时的血清HNL、IL-6、PCT均较入院时下降(P<0.05); 轻中度组治疗前后血清HNL、IL-6、PCT低于重度组(P<0.05); 87例患者均获随访,预后不良患者16例,预后良好患者71例; 预后良好组治疗前后血清HNL、IL-6、PCT均低于预后不良组(P<0.05); 治疗后3 d时血清HNL、IL-6、PCT用于IAI患者28 d预后预测的AUC分别达0.730、0.706、0.685。结论 IAI患者CBP治疗后血清HNL、IL-6、PCT均下降,监测上述指标水平对于病情及预后评估有积极意义。

     

    Abstract: OBJECTIVE To investigate the serum human neutrophil lipocalin (HNL), interleukin 6 (IL-6) and procalcitonin (PCT) levels before and after continuous blood purification (CBP) in patients with intra-abdominal infection (IAI) and their predictive value for prognosis. METHODS A total of 84 patients who were admitted to the ICU from Jan. 2020 to Jun. 2022 and required CBP treatment were selected as the research subjects.According to scores of Acute Physiology and Chronic Health Evaluation System II (APACHE II), patients were divided into mild to moderate group (APACHE II score >10 points, 50 cases) and severe group (APACHE II score ≤10 points, 37 cases).The clinical data of the included subjects were collected and summarized.At admission and 3d after treatment, levels of serum HNL, IL-6 and PCT were detected.The 28 d prognosis was followed up.The predictive value of serum HNL, IL-6 and PCT for prognosis was evaluated by receiver operating characteristic (ROC) curves. RESULTS The levels of serum HNL, IL-6 and PCT of patients at 3 d after treatment were decreased compared with those at admission (P<0.05).Serum HNL, IL-6 and PCT in the mild to moderate group before and after treatment were lower than those in the severe group (P<0.05).All the 87 patients were followed up, 16 patients with poor prognosis and 71 patients with good prognosis.Serum HNL, IL-6 and PCT in the poor prognosis group before and after treatment were lower than those in the good prognosis group (P<0.05).The AUC values of serum HNL, IL-6 and PCT at 3 d after treatment for 28 d prognosis prediction in IAI patients were 0.730, 0.706, and 0.685, respectively. CONCLUSION Serum HNL, IL-6 and PCT significantly decreased in IAI patients after CBP, and monitoring the above indexes had positive significance for disease and prognosis assessment.

     

/

返回文章
返回